CETAPHIL Redness Relieving Daily Facial Moisturizer SPF 40, 1.7 fl oz, Broad spectrum Sunscreen, Neutral Tint, For Redness-Prone Skin
Original price was: $17.99.$15.94Current price is: $15.94.
Price: $17.99 - $15.94
(as of Jul 11, 2024 09:10:32 UTC – Details)
CETAPHIL REDNESS RELIEVING DAILY FACIAL MOISTURIZER SPF 40: Specially formulated for redness-prone skin, this neutral-tinted moisturizer neutralizes the appearance of redness, evens skin tone and hydrates the natural protective skin barrier, leaving it soothed and balanced
BROAD SPECTRUM SPF: Provides thorough sun protection with broad spectrum SPF 40, skin-gentle mineral-based UV filters
SKIN SOOTHING: Formulated with licorice extract, allantoin and caffeine, and is designed to soothe redness-prone skin
HYPOALLERGENIC, FRAGRANCE FREE AND NONCOMEDOGENIC: Nourishes without irritating skin or clogging pores
DESIGNED FOR SENSITIVE SKIN: All CETAPHIL products are effective yet non-irritating
REEF SAFE SUNSCREEN: This product is a reef friendly sunscreen.
User Reviews
Be the first to review “CETAPHIL Redness Relieving Daily Facial Moisturizer SPF 40, 1.7 fl oz, Broad spectrum Sunscreen, Neutral Tint, For Redness-Prone Skin”
Related Products
Le Mieux O2 Calming Gel – Conductive Facial Gel with Aloe – Soothe Mild Visible Irritation & Redness – Hydrating Hyaluronic Acid Gel for Microcurrent Devices – No Parabens or Sulfates (6 oz / 180 ml)
Neutrogena Triple Age Repair Anti-Aging Night Cream with Vitamin C; Fights Wrinkles & Evens Tone, Firming Anti-Wrinkle Face & Neck Cream; Glycerin & Shea Butter, 1.7 oz
La Roche-Posay Mela B3 Serum, Dark Spot Corrector With Anti-Aging Melasyl + 10% Niacinamide, Discoloration Correcting Serum for Sun Spots, Age Spots & Post-Acne Marks, Long-Lasting Results, 30ML
CeraVe Retinol Serum for Post-Acne Marks and Skin Texture | Pore Refining, Resurfacing, Brightening Facial Serum with Retinol and Niacinamide | Fragrance Free, Paraben Free & Non-Comedogenic| 1 Oz
Original price was: $17.99.$15.94Current price is: $15.94.
There are no reviews yet.